Radiofrequency ablation for post infarction ventricular tachycardia
David O'Donnell1, Voltaire Nadurata
1Electrophysiology Unit, Austin Hospital, Heidelberg, Melbourne, Australia. odonnell_research@hotmail.com
Indian Pacing and Electrophysiology Journal
|September 1, 2006
Summary
Radiofrequency ablation effectively manages post-infarction ventricular tachycardia (VT), offering a 70-80% success rate. Advancements suggest expanding its role in treating this complex cardiac condition.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Post-infarction ventricular tachycardia (VT) management is complex.
- Radiofrequency ablation (RFA) is a key therapeutic option.
- Implantable cardioverter defibrillators (ICDs) are common, influencing RFA's role.
Purpose of the Study:
- To review the role and efficacy of RFA in managing post-infarction VT.
- To discuss the technical challenges and current applications of RFA for VT.
- To explore the future potential of RFA in VT treatment.
Main Methods:
- Literature review of RFA for post-infarction VT.
- Analysis of current treatment guidelines and technological advancements.
- Evaluation of RFA success rates and complication profiles.
Main Results:
- RFA is an adjunctive treatment for symptomatic, frequent VT with 70-80% success.
- The procedure is associated with a low complication rate.
- Improved VT prediction and mapping/ablation technologies enhance outcomes.
Conclusions:
- Radiofrequency ablation plays a significant role in managing post-infarction VT.
- Current evidence supports RFA as a safe and effective adjunctive therapy.
- Further advancements indicate an expanding role for RFA in VT management.
Related Concept Videos
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
01:29Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
01:29Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per minute.
01:28Dysrhythmias II: Classification of Tachyarrhythmias
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...